Testolactone CAS:968-93-4

Testolactone Acetate impedit productionem hormonis estrogenii. Quaedam genera cancri pectoris estrogenium ad crescendum requirunt. Testolactonae species aliquas cancer pectoris tractant. Testolactone etiam adhiberi possunt praeter ea quae in hoc medicamento duce enumerantur..

Testolactone Acetate is a synthetic anti-neoplastic agent that is structurally distinct from the androgen steroid nucleus in possessing a six-membered lactone ring in place of the usual five-membered carbocyclic D-ring. Despite some similarity to testosterone, Testolactone has no in vivo androgenic effect. No other hormonal effects have been reported in clinical studies in patients receiving Testolactone.